. Unlike white adipose tissue, which is dement is a major determinant of the survival of all species. signed for energy storage, BAT is designed for the reguFor higher organisms including mammals, a solution to lated expenditure of energy as heat. Neural signals that this problem involved development of the capacity to emanate from the hypothalamus and are transmitted efficiently store excess energy as triglycerides in adiby the autonomic nervous system regulate this highly pose cells, from which stored energy could be rapidly innervated tissue, which employs the uncoupling protein released for use at other sites. In addition, physiological (UCP), a 32 kDa protein of the inner mitochondrial memmechanisms arose to enhance survival by stabilizing brane to uncouple mitochondrial respiration (Jezek et adipose energy stores during prolonged periods of defial., 1994). cient or excess nutritional availability. The outlines of Despite this highly regulated physiological system, such physiological systems are simple: with prolonged it is evident that obesity is currently an exceptionally nutritional deprivation, falling energy stores are sensed, common problem in humans, and the search for causal leading to increased food-seeking behavior and defactors has been intensifying. The last several years creased energy expenditure; with prolonged nutritional have produced breakthroughs in two obesity-related arabundance, food intake is reduced and energy expendieas of investigation: the identification of genetic loci ture is increased to avoid excessive energy storage, i.e.
can be built. The products of the ob and db genes consti-1995). It is likely that an unidentified intrinsic factor such as an intracellular metabolite or another signal whose tute a hormone-receptor pair (leptin and the leptin receptor, respectively) that provides molecular identity to abundance is linked to adipose stores is the major determinant of leptin expression. In addition, a number of one system through which the status of energy stores is signaled to the brain. Total inability to produce leptin factors that are extrinsic to the adipocyte can regulate leptin expression both in vitro and in vivo, over a period (ob/ob) or respond to it (db/db) result in profound, early onset obesity with persistently excessive food intake, of hours, in some cases changing leptin expression out of proportion to changing fat stores. These include insuinappropriately decreased energy expenditure, severe insulin resistance, and genetic background-dependent lin (MacDougald et al., 1995a) , glucocorticoids (Slieker et al., 1996) , beta adrenergic ligands (Mantzoros et al., diabetes . Repletion of ob/ob mice with recombinant leptin is remarkably effective at reversing all aspects of the 1996), and cytokines (Grunfeld et al., 1996) . Although the putative role of leptin as a long term integrative syndrome so far studied over a period of days to weeks (Halaas et al., 1995; Pellymounter et al., 1995;  Campfield signal of energy stores suggested that leptin levels would change slowly, it appears that short term changes et al., 1995; Chehab et al., 1996) . Weight loss following leptin treatment of ob/ob mice results from both reducin leptin levels may have important consequences as well. tion in food intake and increased energy expenditure Halaas et al., 1995; The functional analysis of the leptin promoter is at an early stage; functional C/EBP binding sites are present et al., 1995) . Energy expenditure is mediated by both increased physical activity and activity-independent (He et al., 1995; Hwang et al., 1996) . Thiazolidinediones reduce leptin mRNA (Zhang et al., 1996) , consistent with thermogenesis, which in part appears to involve activation of brown adipose tissue (Collins et al., 1996) . Reverinvolvement of PPAR␥ on the leptin promoter (Kallen and Lazar, 1996) . Cloning and identification of the leptin sal of insulin resistance and diabetes in ob/ob mice by leptin is in part a consequence of reduced food intake receptor DNA reveal it to be a member of the class I cytokine receptor family that signals, at least in part, and body weight, but the rapid time course and dose response for such effects suggests that additional acthrough the Jak/STAT pathway (Ghilardi et al., 1996) . The leptin receptor gene is complex, producing multiple tions of leptin may be involved, acting either directly through peripheral sites, or more likely, through the brain splice variants expressed at very low levels in a tissue specific manner . The db allele encodes . Although administration of exogenous leptin can limit the obesity that occurs when cera mutation in the non-coding region that alters splicing and results in deletion of most of the intracellular, signaltain strains of normal mice are exposed to high fat diets (diet-induced obesity) (Campfield et al., 1995) , the doses ing domain . The predominant site in which this "signaling" form of the required are high compared to those that are effective in ob/ob mice, and it is not yet established whether receptor is expressed appears to be the hypothalamus, but the mRNA for this form is also seen at lower abunphysiological resistance of normal mice to obesity caused by high fat feeding or other environmental stimuli dance elsewhere as detected by RT-PCR. Missense mutation of the leptin receptor gene has also been deis mediated by increased levels of endogenous leptin. High levels of circulating leptin and what is now being scribed in the Zucker fa/fa rat (Phillips et al., 1996; Chua et al., 1996) . One or more short forms of the receptor referred to as "leptin resistance" are found in the vast majority of obese humans so far reported (Considine et that are unlikely to have signaling potential are heavily expressed in several tissues including the choroid al., 1995; Maffei et al., 1995) .
How Does This System Work?
plexus, where the receptors may mediate uptake across the blood-cerebral spinal fluid barrier. The possibilities In the fed state, leptin is expressed and secreted by adipocytes in proportion to their triglyceride stores, and of blood-brain barrier transport or direct access to sites in the brain that reside outside the blood brain barrier circulates in the blood where its levels correlate to a remarkable degree with the extent of obesity (e.g. Fred- have not been excluded. What appears to be a saturable system for transport of leptin from blood to brain has erich et al., 1995a; Maffei et al., 1995; Considine et al., been described in vivo in rats (Banks et al 1996) , and in serotonin and norepinephrine, is in an embryonic stage normal humans, levels of leptin in cerebral spinal fluid and will be an important subject for future research. are approximately 2-5% of serum levels (Schwartz et Role of Leptin: Obesity vs Starvation? al., 1996) . Initial reports suggest that the ratio of cerebral
The discovery of leptin and its receptor as genetic loci spinal fluid to plasma leptin shows characteristics of carrying mutations that cause severe obesity in rodents saturability when leptin levels in plasma rise to the level suggested to most observers that one physiological role seen in obesity Caro et al., 1996) , of leptin is to prevent obesity during exposure to nutriand this could be one of the factors that might limit the tional excess (i.e. a negative feedback "adipostatic" ability of peripheral leptin to effectively signal the state function). However, it is not clear that prevention of of adiposity to the central nervous system. obesity is leptin's most important role or the problem Leptin Targets that the leptin system evolved to address. What other Identifying targets for leptin action in the brain is a matter role might leptin be playing? In addition to rising as of great interest, both from scientific and pharmaceutienergy stores increase, leptin levels were noted to fall cal perspectives. One target for leptin action is the level with weight loss Maffei et al. , of expression of the hypothalamic neuropeptide Y (NPY) 1995; Considine et al., 1995) . Since an effective adapta- (Dryden et al., 1994) . This 36 amino acid peptide is extion to starvation would offer a survival advantage under pressed widely throughout the nervous system. Expresthe conditions of intermittent food supplies that is likely sion of NPY mRNA in the arcuate nucleus of the hypoto have confronted mammals through evolution, it is thalamus is increased in ob/ob and db/db mice and in possible that leptin evolved to provide a signal to inform response to fasting in normal rats (Marks et al., 1992) . the brain that energy stores are sufficient, and, in paralRepetitive administration of NPY into the central nervous lel, to entrain the brain's response to starvation. Recent system produces hyperphagia and obesity (Stanley et experiments support this hypothesis (Ahima et al., 1996) . al., 1986) decreased energy expenditure with suppresSeveral changes in neuroendocrine status accompany sion of BAT activity (Billington et al., 1991) , and hyperinfasting or limitation of food intake. These adaptations, sulinemia (Zarjevski et al., 1993) , all features of obesity which include limitation of reproductive competence, in ob/ob and db/db mice. On the basis of its pattern of reduced thyroid hormone levels, and activation of the nutritionally regulated expression in the arcuate nupituitary-adrenal "stress" axis are prevented or blunted cleus, and the consequences of its direct administration when leptin levels are replaced exogenously during a into the brain, NPY has been proposed to be a key fast (Ahima et al., 1996) . The dose of leptin required for effector of the hypothalamic regulation of nutritional hothese neuroendocrine actions is lower than the dose meostasis; it's overexpression may be an important link required to produce weight loss in normal rodents. In between leptin deficiency and the development of obeaddition, except for ob/ob mice, which are very sensitive sity. Since leptin treatment of ob/ob mice suppresses to leptin, obesity in most rodent models (Frederich et NPY expression in the arcuate nucleus (Stephens et al., al., 1995 (Stephens et al., al., , 1995a Maffei et al., 1995) and in most human 1995; Schwartz et al., 1996) , and leptin may act directly obesity is associated with high on NPY-expressing cells in vitro (Stephens et al., 1995) , levels of leptin and what is being referred to as "leptin the NPY neuron is likely to be a key leptin target. The resistance." It is not yet clear whether "leptin resistance" recent identification of a new species of NPY receptor reflects widespread disease due to dysfunction in path-(Y5) that has characteristics expected of a receptor that ways downstream of leptin, or the inherent physiologic mediates the action of NPY on food intake (Gerald et limitations of the putative role of leptin as a signal to al., 1996) is a potentially important advance. However, prevent obesity. This question will only be answered by the precise role of NPY is made less clear by the phenocareful studies of leptin physiology in lean and obese type of NPY knockout mice, which apparently regulate animals and humans under a variety of nutritional condifeeding and body weight normally, and respond to exogtions and genetic analysis of the pathways downstream enous leptin with normal or even excessive inhibition of of leptin in lean and obese individuals. food intake (Erickson et al., 1996) . Whether absence of Agouti, Fat, Tub NPY will alter the phenotype of mice with various forms Whereas identification of ob and db established a deof obesity will presumably soon be known through physfined physiological loop, the identity of the agouti, fat iological studies and genetic crosses. Whatever the reand tub mutations has yet to elucidate the physiological sults of such experiments, it already seems clear that system that is perturbed by these mutant alleles to prosuppression of arcuate NPY cannot be the sole mechaduce obesity. The obesity in these models develops nism for leptin action to regulate body weight, and one or more slowly than is seen with ob or db, although in each more other central leptin targets must exist. One recent case an action of the mutant gene product in the central candidate for an alternative leptin target is melanin connervous system is suggested. Lethal yellow (A y ) is an centrating hormone, a neuropeptide that is expressed autosomal dominant syndrome of obesity with insulin predominantly in the hypothalamus, is overexpressed resistance, diabetes, and yellow coat color that is due in ob/ob and starved normal mice, and causes hyperto widespread ectopic expression of the agouti protein phagia after injection into the lateral cerebral ventricles (Bultman et al., 1992) . This gene, which was the first of rats . Neuropeptides that inhibit food obesity locus to be cloned, encodes a 131 amino acid intake, such as corticotropin releasing hormone (Arase protein that is normally expressed solely in skin during et al., 1988) are also potential targets of leptin. Our unhair growth, where it influences hair pigmentation and derstanding of how these and other central neuropepcoat color (Manne et al., 1995) . It does this by antagoniztides interact, with each other and with classical neurotransmitters that regulate feeding behavior such as ing the binding of melanocyte stimulating hormone to one or more melanocortin receptors on the melanocyte mass index can be ascribed to genetic factors (Bouchard, 1995) . In rare cases, human obesity is the conse- (Lu et al., 1994 and do not appear to be human equivalents of any of 1979). This parallel suggests that agouti might cause the identified mouse obesity genes. obesity by mimicking an action of melanin concentrating
In most human obesity, it is believed that a limited hormone to antagonize melanocyte stimulating hornumber of genes interact with the environment to promone or a melanocyte stimulating hormone-like moleduce the final phenotype, and several strategies have cule at one or more sites in the brain.
been used to search for such genes. Candidate genes The fat mutation produces an autosomal recessive have been chosen for analysis based on the roles that obesity with hyperinsulinemia that was assumed to be their gene products are thought to play in the regulation compensatory to insulin resistance, as in other obesity of energy balance. In large studies of the ob gene (Conmodels (Coleman and Eicher, 1990) . It was found, howsidine et al., 1995; Maffei et al., 1996) , and a limited ever, that these mice responded normally to exogenous study of the ob receptor gene in insulin, and that much of the circulating insulin was an obese humans, functionally significant mutations within incompletely processed and biologically less active the coding regions of these genes have not been found. form. The molecular explanation arrived when the fat On the other hand, linkage between the ob gene has mutation was mapped to the carboxypeptidase E gene, been found in some ; Reed et al., with fat being a missense mutation that abolishes en-1996) obese populations, and in an Hispanic population, zyme activity in extracts of pancreatic islets and pituitary obesity has been linked to a region of the genome (1p22- (Naggert et al., 1995) . Precisely how obesity and accomp31) (Duggirala et al., 1996) to which the leptin receptor panying infertility result from a defect in prohormone also maps. Linkage of human obesity to human tub, fat, processing is as yet unknown, but speculation has cenor agouti genes has not yet been reported. Three other tered on the possibility that defects in processing of candidate genes for which linkages of as yet uncertain hypothalmic neuropeptides may be the answer. This significance have been reported are worthy of note. idea is supported by a recent report that processing of These include the beta 3 adrenergic receptor (Widen et hypothalamic neuropeptides is abnormal in fat/fat mice, al., 1995), which could be linked to functional impairment with one unexpected result being increased level of the in lipolysis in white adipocytes or thermogenesis in BAT; aforementioned neuropeptide melanin concentrating the glucocorticoid receptor (Clement et al., 1996a) , hormone (Rovere et al., 1996) . A potential human homowhich could influence obesity through the known ability log of this disorder has recently been described in an of glucocorticoids to act permissively at a number of obese patient with high levels of incompletely processed key steps in energy balance; and the Na ϩ ,K ϩ ATPase insulin and proopiomelanocortin (O'Rahilly et al., 1995) , (Deriaz et al., 1994) , whose function in maintenance of but whether the genetic basis for this disorder involves ion gradients contributes importantly to energy expencarboxypeptidase E or another prohormone processing diture. enzyme, such as prohormone convertase 1 (PC1), has not yet been established.
The most recent obesity gene to be identified is tub, Control of Adipose Cell Size and Number another autosomal recessive obesity of later onset, in When the intake of energy chronically exceeds energy which retinal degeneration and neurosensory hearing expenditure, most of the excess energy is stored in loss are found (Coleman and Eicher, 1990) . The tub gene the form of triglycerides in adipose tissue. Increased was identified through positional cloning and encodes adipose tissue mass can arise through an increase in cell a novel and highly conserved 505 amino acid protein size, cell number, or both. Adipose cells are remarkably that is suggested to be cytosolic in location (Nobenvariable in size, reflecting principally the amount of Trauth et al., 1996; Kleyn et al., 1996) . It is most highly stored triglyceride. Mild obesity mainly reflects an inexpressed in eye, testis, and brain, where location in creased adipose cell size (hypertrophic obesity) while hypothalamic nuclei important for regulation of body more severe obesity or obesity arising in childhood typiweight is consistent with tub playing a role somewhere cally also involves an increased fat cell number (hyperin the pathway for neural regulation of energy balance. plastic obesity). As a key part of a homeostatic system Another approach to identification of genes involved controlling energy balance, the molecular mechanisms in the obesity phenotype has involved quantitative trait that regulate preadipose cell growth, adipose differentilocus mapping, using intercrosses between strains of ation, and lipogenesis in fat cells have been subject to rodents with high or low susceptibility to diet induced extensive scrutiny. Recent years have seen an explosive obesity. Some of the identified loci appear to map close increase in our understanding of the transcriptional bato one or more of the identified mouse obesity genes sis of fat cell differentiation and adipose cell gene ex-(e.g., West et al., 1995) .
pression, particularly the identification of transcription Genetic Basis for Human Obesity factors that can promote adipogenesis in a dominant Studies in twins, adoptees, and families suggest that fashion. Central to our understanding here are PPAR␥, the C/EBPs and ADD1/SREBP1. from 40% to as much as 80% of the variance in body PPAR␥ is a member of the PPAR (peroxisome proliferthat PPAR␣ can induce some adipogenesis when stimulated by its strongest activators, while PPAR␦ could not ator activated receptor) subfamily of nuclear hormone receptors. PPAR␥ exists as two isoforms (␥1 and ␥2) stimulate detectable fat cell formation (Brun et al., 1996) . Since many fibroblastic cells express a low but detectformed by alternative splicing (Zhu et al., 1995) and differing in their N-termini (Tontonoz et al., 1994a) . PPAR␥2 able level of PPAR␥, it seems likely that the previous suggestions of an adipogenic response through PPAR␦, is expressed at high levels in adipose tissue, while low levels of PPAR␥1 can be found in many other tissues.
especially when stimulated with high levels of nonselective PPAR activators, were actually due to the actiThis receptor is induced very early in adipose cell differentiation, and is present at higher levels in preadipovation of PPAR␥. While PPAR␣ stimulated differentiation was less extensive and slower than that stimulated by cytes than other fibroblastic cells. PPAR␥ appears to function as both a direct regulator of many fat-specific PPAR␥, the same basic program of gene expression was observed. Hence, the possibility exists that PPAR␣ genes and also as a "master" regulator that can trigger the entire program of adipogenesis. PPAR␥ forms a hetmay contribute to the adipogenesis of some depots, in normal or pathological states. As specific high affinity erodimer with RXR␣ and has been shown to bind directly to well characterized fat-specific enhancers from the ligands become available for all of the PPARs, a much more critical analysis of their function will be possible. adipocyte P2 (aP2; Tontonoz et al., 1994a) and phosphoenolpyruvate carboxykinase (PEPCK) genes (Tontonoz The C/EBPs and a Transcriptional Pathway for Adipogenesis et al., 1994b) . In fact, PPAR␥ was cloned as a component of a transcription factor, ARF6, that bound to the aP2 PPAR␥ is not the only transcription factor that is significantly elevated in adipocyte differentiation. C/EBP␣, ␤, enhancer (Tontonoz et al., 1994a) , and it was cloned independently through homology screens seeking new ␦, and ADD-1 (also called SREBP-1) are all markedly induced during differentiation in culture, although they members of the PPAR family (e.g., Zhu et al., 1993) . As a member of the nuclear receptor family, the ability of are not expressed in an adipose-selective fashion in vivo. C/EBP␣ is increased relatively late in the process PPAR␥ to increase transcription through its DNA recognition site (DR-1, direct repeat, 1 base spacer) depends of adipogenesis but ectopic expression of high levels of this factor alone can induce the differentiation of many on the binding of ligands. Earlier work with PPARs relied on "activators" that presumably functioned by stimulatfibroblastic cell lines (Freytag et al., 1994) . On the other hand, when expressed at or near the mRNA levels seen ing the intracellular production of ligands. These activators include drugs that caused peroxisome proliferation in mature fat cells, this factor has only a modest adipogenic action in fibroblasts (Tontonoz et al., 1994c) . Pre-(hence the name PPAR) such as clofibrate, ETYA, Wy14,643, as well as a variety of other fatty acid derivacocious expression of C/EBP␣ can accelerate the endogenous differentiation program of preadipocytes, tives (e.g., Green and Wahli, 1994) . Most recently, the first direct ligands for PPAR␥ have been described inwhile antisense mRNA blocks the differentiation markedly (reviewed by MacDougald and Lane, 1995) . The cluding 15-deoxy⌬12,14 prostaglandin J2 (15dPGJ) and the thiazolidinediones, an exciting new class of insulinimportant role of C/EBP␣ in adipose development is clearly shown in a knockout mouse. This genetic disrupsensitizing drugs in clinical development for non-insulin dependent diabetes mellitus (discussed below).
tion causes a major reduction in the lipid content of the fat tissue; however, fat cell differentiation apparently The regulatory role that PPAR␥ can play in adipogenesis is vividly illustrated through ectopic expression of still occurs . C/EBP␣, like PPAR␥, directly binds to many fat cell-specific genes (MacDouthis receptor. When expressed with viral vectors at or below the levels normally seen in fat cells, fibroblasts gald and Lane, 1995). Unlike PPAR␥, which tends to bind to distal enhancer regions, C/EBP tends to bind at are efficiently converted into bona fide adipocytes upon application of PPAR␥ activators or ligands (Tontonoz et sites clustered in proximal promoter regions. A dramatically cooperative or synergistic relationship al., 1994c). In fact, using pioglitazone, a thiazolidinedione ligand, greater than 95% of these cells can be differbetween PPAR␥ and C/EBP␣ is observed when both of these factors are expressed in the same cells. Under entiated to fat (Brun et al., 1996) . This adipogenic response is apparently through the transcriptional activity conditions lacking a PPAR␥ activator, where neither factor alone promoted significant adipogenesis in of PPAR␥, since a point mutation in one of the zinc fingers required for DNA binding completely ablated this fibroblasts, coexpression gave abundant differentiation (Tontonoz et al., 1994c) . This cooperation is even more action (Tontonoz et al., 1994c) . The adipogenic activity of PPAR␥, like the well established 3T3-L1 and 3T3-obvious when a cell with little adipogenic potential, such as a determined myoblast, is challenged with these fac-F442A preadipocyte cell lines, is markedly enhanced by the presence of insulin .
tors. Neither C/EBP␣ or PPAR␥ (with activator) alone could give rise to fat differentiation from G8 myoblasts, Since all of the PPARs (␣, ␦, and ␥) can bind to the same DNA sequences, and all are expressed in at least but coexpression caused the differentiation of at least 70% of these cells into adipocytes . some fat depots, it is interesting to know whether ␣ and ␦ (also called NUC-1 or FAAR) play any role in adipogenThus, while either PPAR␥ and C/EBP␣ can promote adipogenesis under very favorable experimental condiesis. Unlike PPAR␥, PPAR␣ or ␦ are not expressed preferentially in fat, but there have been suggestions that tions, such as in a very susceptible precursor cell or with the application of high levels of adipogenic hormones or both of these receptors could play a direct or indirect role in adipogenesis (Yu et al., 1995; Teboul et al., 1995 (Yeh et al., 1995) . Of the that ADD1/SREBP1 is regulated dramatically in fat cell differentiation and has been shown to function positively two major forms of the C/EBP␤ protein, liver-enriched activating protein (LAP) has much more activity than liver in adipogenesis , but is not observed to be activated through proteolytic cleavage enriched inhibitory protein (LIP). Notably, expression of C/EBP␤, which is normally induced very early in adipoupon cholesterol depletion of hamster liver (Zheng et al., 1995) . In contrast, SREBP2 is proteolytically activated genesis, increases the expression of PPAR␥ . The differentiation of cells expressing C/EBP␤ upon development of a cholesterol-depleted state, and hence may play the more important role in cholesterol ectopically is dependent on the addition of a PPAR activator, suggesting that an important role of C/EBP␤ in homeostasis in vivo (Zheng et al., 1995) . The relative roles of these two proteins is being critically analyzed adipogenesis may be to turn on PPAR␥ expression. C/EBP␦ has also been implicated in the regulation of in several cellular and genetic systems. The outlines of a regulatory loop involving the key PPAR␥; coexpression of both C/EBP␤ and ␦ is necessary to fully induce PPAR␥ to levels seen in adipocytes adipogenic factors during differentiation can now be envisioned (Figure 1 ). C/EBP␤ and ␥ are elevated quite . The promoter for PPAR␥2, the isoform expressed most selectively in fat, contains two C/EBP early in this process, probably in response to certain hormones, and may function directly to increase the binding sites (Zhu et al., 1995) , suggesting a direct regulatory circuit.
expression of PPAR␥. If the extracellular and intracellular conditions provide the necessary adipogenic horAnother factor that appears to interact directly or indirectly with PPAR␥ is ADD1/SREBP1. This protein was mones and PPAR␥ ligands, the transcriptional activity of this molecule will begin the cascade of genes that cloned independently as a basic helix-loop-helix (bHLH) protein induced very early in adipogenesis (Tontonoz et constitute the process of adipogenesis. ADD1/SREBP1 promotes this process by augmenting the transcripal., 1993), and a sterol response element (SRE) binding protein (Yokoyama et al., 1993) . This factor is quite untional ability of PPAR␥. Since PPAR␥ activation results in the expression of most or all of the program of differusual in that it has dual specificity in DNA binding, interacting with certain E-box sequences and the SRE. Dual entiation, including C/EBP␣, it is reasonable to imagine that PPAR␥-C/EBP␣ cooperation brings about maximal specificity is controlled by a single tyrosine residue in the basic DNA binding region, at a site where all other differentiation and a full program of lipogenesis. The ability of PPAR␥ and C/EBPs to engage in cross-regulabHLH factors have an arginine . SREBP1 and its close homolog SREBP2 are posttranscriptionally tion may be sufficient to maintain the differentiated state, once it has been initiated. Of course, maintaining activated by proteolytic cleavage of a large, transmembrane form of the protein . When this regulatory loop will require the generation of an endogenous PPAR␥ ligand. The ability of ADD1/SREBP1 expressed ectopically in fibroblasts ADD1/SREBP1 has two notable activities. Under culture conditions not conto regulate both key genes of fatty acid metabolism and augment PPAR␥ activity suggests that this transcription ducive to adipogenesis, it induces two key genes of fatty acid metabolism, fatty acid synthetase and lipoprotein factor may be important in the process of ligand generation. lipase, without stimulating visible fat cell formation . Under conditions strongly faSeveral major unanswered questions remain in this scheme. If C/EBP␤ is a major inducer of PPAR␥ in vivo, voring adipogenesis, ADD1/SREBP1 can increase the percentage of fibroblasts that undergo differentiation why is PPAR␥ not expressed abundantly in other tissues that express high levels of C/EBP␤, such as liver? This from 2-3% to 15-20%. This effect is probably due, at least in part, to an influence of PPAR␥ activity, since suggests the involvement of other important regulators, positive or negative, in fat and non-adipose tissues. A cotransfection with ADD1 causes a 3-4 fold increase in the activity of PPAR␥ through its DNA binding site but second question relates to the quantitative regulation of C/EBP␣ in fat. Although expression and activation of has no influence on the activity of C/EBP␣ through its DNA recognition sequence . PPAR␥ in fibroblasts is sufficient to give some expression of C/EBP␣, it is much lower than the expression in In parallel with these studies, the lab of Brown and Goldstein has implicated ADD1/SREBP1 and SREBP2 normal adipose tissue, again arguing for the involvement of as yet undescribed molecules. It will also be important in the control of several key genes of cholesterol homeostasis (Yokoyama et al., 1993) . This suggests that this to understand the mechanisms of cooperation between PPAR␥ and C/EBP␣ in differentiation. How this cooperafamily of factors could coordinate the regulation of two of the major lipid pathways, those leading to fatty acids tion occurs at a molecular level is not clear. Since many fat cell-specific genes have binding sites for both proand cholesterol. Since the construction of very low density lipoproteins (VLDL), the parents molecule of IDL and teins, a highly synergistic interaction with the core transcriptional machinery is the simplest explanation. The LDL, contains both lipids, it is likely that the dual action of the ADD1/SREBP family reflects the need to coordispecificity of the PPAR␥-C/EBP␣ relationship is indicated by the fact that other PPARs do not synergize nate these two separate but related metabolic pathways. In this regard, it will be interesting to know whether with C/EBP␣ in adipogenesis. It is also possible that C/EBP␣ activates genes whose products control endogthe two different pathways in which these transcription factors participate segregate along the lines of E-box enous PPAR␥ ligand formation. Finally, a direct proteinprotein interaction that increases the activity of one or versus SRE binding. Also interesting is the possibility that one of these two isoforms is primarily involved in both of these factors has not been ruled out. One crucial question that has not yet yielded to current The better-studied prostaglandin hormones are known to act via cell surface receptors. However, the investigation is the transcriptional control of white vernotion that these lipids can permeate cell membranes sus brown adipose differentiation. As described above, and enter the nucleus is feasible. It is not yet known white fat cells and brown adipose cells play opposite whether 15-dPGJ2 is generated in cells undergoing adiroles in energy homeostasis although they express a pogenesis at levels that would suggest that it could very similar pattern of genes. Since the key component function as a true endogenous ligand for PPAR␥. of energy dissipation employed by brown adipose cells Thiazolidinediones (TZDs) are an exciting new class is UCP, it seems likely that a hint about the key differentiof synthetic drugs that increase sensitivity to insulin in ation factors might come from the study of this gene.
patients that are resistant to this hormone. Since insulin Recent data suggests that this promoter, like many resistance is a ubiquitous correlate of obesity and a genes expressed in white adipocytes, has regulatory major component of the form of diabetes (non-insulin sites for the C/EBPs and PPAR␥ (Yubero et al., 1994;  dependent diabetes mellitus, NIDDM) commonly associ- Sears et al., 1996) , both of which are expressed in BAT ated with obesity, these drugs may have great medical and WAT. Hence, it is likely that other transcription facimportance. Currently, one member of this class, troglitors or modified versions of these factors must contribtazone, has reported successful results in a phase III ute to the critical divergence in the determination of clinical trial to treat NIDDM (Nolan et al., 1994) . The these two cell types.
connection between the thiazolidinediones and PPAR␥ PPAR␥ Ligands: Natural and Synthetic was first prompted by the studies of Rolf Kletzien and The nuclear receptors are built to receive chemical sigcolleagues. They showed that pioglitazone could specifnals that trigger their activity. Since at least one activity ically induce the aP2 gene in differentiating adipocytes, of PPAR␥, to promote adipogenesis, is both very draand this drug appeared to function through the prematic and of considerable physiological importance, viously identified differentiation control element, ARE6, there has been an immediate surge of activity to identify in the aP2 enhancer (Harris and Kletzien, 1994) . After ligands, both natural and synthetic. the ARE6 binding factor (ARF6) was cloned and shown The identification of a natural ligand for PPAR␥ was to be PPAR␥ (Tontonoz et al., 1994a) , Ibrahimi et al. preceded by research showing that many polyunsatu- (1994) found that TZDs could activate PPARs, though rated fatty acids and eicosonoid derivatives, such as they did not examine PPAR␥. In fact, the anti-diabetic ETYA and Wy14,643, were activators of the PPARs TZDs BRL49653 and pioglitazone elicit a strong activa- (Green and Wahli, 1994) . Using transcriptional activation tion of PPAR␥, with relatively little activity on PPAR␣ through a reporter gene as an assay, it was found that and ␦ (Lehmann et al., 1995; Forman et al., 1995) . Using the prostaglandin D arm of this family had high activity 3 H-BRL49653, this drug was shown to bind directly to (Forman et al., 1995; . 15-dPGJ2 was PPAR␥, while binding to the other PPARs was not depotent and gave a rapid response, consistent with a tectable. The rank order of potency of the TZDs closely direct interaction with this receptor. Indeed, two groups matches the anti-diabetic action, suggesting that PPAR␥ found that this prostaglandin could bind directly to is the functional receptor in this action (Willson et al., PPAR␥, as evidenced by competition for binding with a 1996). As expected for an agonistic ligand, these comsynthetic thiazolidinedione ligand (see below), with a Ki pounds have very powerfully adipogenic action in cells of ‫2ف‬ M. As expected for a direct agonist, it is very ectopically expressing PPAR␥, or in fibroblastic cells effective at promoting adipogenesis when added to cells that express low but significant amounts of this receptor. It is worth noting that TZDs had been reported to that express PPAR␥. stimulate the differentiation of preadipocyte cell lines Finally, it should be appreciated that these models well before the identification of PPAR␥ as a target (Kletare not mutually exclusive. It is entirely possible that all zien et al., 1992).
of these mechanisms contribute and the quantitative PPAR␥ and Insulin Resistance importance of each can only be ascertained through a The activity of TZDs to promote adipogenesis in culture combination of genetic studies, especially tissue-speand improve insulin sensitivity in vivo may seem paracific knock-outs of PPAR␥, and studies of whole body doxical in that increased adipogenesis is most comphysiology. monly associated with obesity, a condition tightly linked to insulin resistance. However, this paradox becomes Linking Ingestive Behavior to Adipogenesis less troubling when one remembers that obesity is funGiven the rash of recent insights into obesity genes and damentally a disorder of energy balance, with the excess adipocyte biology, the task remains to integrate these energy stored in fat. Indeed, adipose differentiation itself often disparate new findings, first with each other, and is associated with the development of a marked increase then with knowledge of classical metabolism, endocriin insulin sensitivity, correlating with greater expression nology and nutrition, to create a more complete underof the insulin receptor, IRS-1, GLUT-4 and probably standing of the biology of weight regulation and obesity. many other genes that are fundamental to the metabolic Although we are still a long way from such a synthesis, response to insulin. Excessive adipocyte number is only the outlines of some new connections can now be seen. contributory to insulin resistance when it is linked (as it One need not be a rocket scientist to notice that inusually is in vivo) with an excessive burden of stored creased food intake tends to be associated with obesity, energy.
but it is less obvious by what mechanisms increased One can imagine several plausible mechanisms for ingested nutrients are transformed into more and bigger TZD-improved insulin sensitivity. It is likely that one or fat cells. Following the ingestion, digestion, and absorpmore key genes relating to insulin action are capable tion of nutrients, levels of substrates rise, and these, of being modulated by an increased activity of PPAR␥ along with signals emanating from the gut, produce activity, even in fully differentiated fat. A TZD ligand, changing levels of hormones that guide the substrates given at pharmacological doses, would be expected to to their sites of storage. Insulin is the preeminent horcontrol such genes and improve the insulin sensitivity mone of the fed state: elevated levels prevent excessive of this tissue. Of course, a major question is how can rises in blood glucose by promoting glucose storage TZDs improve insulin sensitivity of muscle and liver, and use and decreasing glucose production by the liver. other tissues that are important targets of insulin. One
Insulin also has a critical role in lipid metabolism, propossibility is that TZDs function in a similar manner demoting the storage of triglycerides in adipocytes through scribed above through the low levels of PPAR␥ that are numerous actions on this cell. Among these are stimulaexpressed in many non-adipose tissues. Alternatively, tion of glucose uptake and inhibition of lipolysis, which adipose tissue PPAR␥ might be the primary target of occur very rapidly through glucose transporter protein TZDs but this might result in the generation of signals (GLUT 4) translocation or covalent modification of horfrom fat that affect insulin sensitivity in muscle and liver. mone sensitive lipase, respectively. Insulin also stimuSimply by virtue of improving insulin sensitivity in fat, the lates fatty acid and triglyceride synthesis, through the rate of fatty acid release would be expected to decrease, induction of key lipogenic enzymes such as fatty acid since the suppression of lipolysis is a major action of synthetase and glycerophosphate dehydrogenase, and insulin. In addition, fatty acids have been shown to be induction of lipoprotein lipase. To this picture of insulin capable of inducing insulin resistance (Svedberg et al., action, we can now add recent insights into adipogenic 1991). There may also be protein products of fat that transcription factors. It is clear that an insulin signal affect systemic insulin sensitivity and are regulated by promotes the adipogenic action of PPAR␥, since differTZDs. One example of this is known: tumor necrosis entiation of cells expressing this molecule is greatly infactor ␣ (TNF␣). As mentioned above, TNF␣ produced creased by this hormone . The nature in fat has been implicated in systemic insulin resistance, of this signal is not yet characterized. Although an insulin especially in obesity (reviewed by Hotamisligil et al., stimulated change in PPAR phosphorylation and func-1996) . TZDs have been shown to affect 2 arms of the tion may be predicted based on observations with other TNF pathway: it reduces TNF␣ expression in fat tissue members of the steroid receptor superfamily (Bunone in vivo (Hofmann et al., 1994) and it can also block certain et al., 1996) , it has also been observed that the abunactions of TNF␣ on preadipose and adipose cell cultures dance of PPAR␥ isoforms in fat falls with starvation and . Whether TZD can specifically insulin deficiency diabetes (Vidal-Puig et al., 1996) . This interfere with the action of TNF␣ to inhibit signaling could occur through regulation of C/EBP␤ and ␦, which through the tyrosine kinase activity of the insulin recephave themselves been shown to be transiently induced tor has not yet been investigated. A further contributing by insulin in cell culture (MacDougald et al., 1995b) . fact to improved insulin sensitivity might be if TZDs do Thus, the actions of insulin to transduce the nutritional trigger more, smaller cells. It has been suggested that state of the organism to molecular machinery linked to smaller fat cells tend to have greater insulin sensitivity production of new fat cells may involve changes in both than large, more lipid-laden cells (Abbott and Foley, the levels and functional state of PPAR␥ as well as 1987). A redistribution of lipid into more cells could in-C/EBP␤ and ␦. Another positive link between adipogencrease insulin sensitivity, but since the adipose mass is esis and insulin involves ADD1/SREBP1. This molecule, a less significant sink for glucose disposed than muscle, which promotes adipogenesis and fatty acid metaboit is not clear how large an increase in insulin sensitivity this could generate.
lism, has been shown to be influenced by the presence The white adipocyte produces leptin as a function of adipose energy stores. Leptin acts through receptors in the hypothalamus to regulate appetite, BAT activity and insulin secretion via sympathetic nervous system (SNS) output, and neuroendocrine function, including reproduction. Ingested nutrients stimulate insulin secretion, and together these may act through several transcription factors to promote adipose differentiation and lipogenesis. Adipocytes secrete proteins in addition to leptin which may have the capacity to act locally and/or systemically to influence energy balance.
of insulin. While ADD1/SREBP1 activity has been shown in both preadipose cells and mature adipocytes is an important area for future study. to be increased by insulin, it is not yet clear whether this occurs by protein modification or at some other level (Streicher et al., 1996) . Taken together, it appears Energy Balance: Elements of a Homeostatic Cycle It is now clear that the systems that influence food intake that the response to feeding, at least in part via insulin, promotes both energy storage in fat and the adipogenic and adiposity can be viewed as a cycle, as shown in Figure 2 . As discussed above, the key elements are program itself through PPAR␥ and perhaps ADD1/ SREBP1. Paradoxically, C/EBP␣ levels have been demlikely to be the fat-produced hormone leptin, the neural system for integration of signals related to energy balonstrated to be negatively regulated by insulin. While this effect cannot explain the positive role of insulin in ance, the pancreatic production of the hormone insulin and the effects of this hormone and eicosonoids on adipogenesis, it may contribute to the downregulation observed in certain fat cell genes, such as GLUT4, in adipogenic transcription factors, particularly PPAR␥. However, it would be extremely naive to think that these response to insulin (MacDougald et al., 1995b) .
Glucocorticoids also represent a potentially important are the only important players in the fat-brain homeostatic system. Indeed, several other novel proteins selink between obesity genes and adipogenesis. Many of the monogenic obesity syndromes in rodents develop creted by fat that enter the circulation have been described, though their function is not yet known. These a hyperglucocorticoid state and reversal of this state with adrenalectomy profoundly reduces obesity and include adipsin (Flier et al., 1987) , angiotensinogen (Frederich et al., 1992) , plasminogen activator inhibitor I several linked metabolic disorders. It has recently been shown that the induction of PPAR␥ by C/EBP␤ and ␦ (PAI I; Samad and Loskutoff, 1996) , and ACRP30/adipoQ Scherer et al., 1995) . It is highly likely that depends almost entirely on the presence of a glucocorticoid . This induction of PPAR␥ does not other fat derived molecules with interesting systemic functions will be described. Similarly, the wiring diagram require ongoing protein synthesis, and hence, is likely to represent a direct action of the liganded glucocorticoid of neural signaling molecules is very much at an exploratory stage. Although many neuropeptides are known receptor on the PPAR␥ promoter.
Another potentially direct link between diet and adipoto affect food intake, their relative importance in various nutritional states and the manner in which these neurogenesis involves the natural ligands for PPAR␥. Many PPAR␥ activators and the only identified biological litransmitters and neuromodulators interact must be determined. gand (15-dPGJ2) are eicosanoid derivatives. All eicosanoids are derived from arachidonic or other essential It is fair to ask what implications arise from this new concept of a homeostatic cycle, in terms of our underpolyunsaturated fatty acids that must be supplied through the diet. It is not clear whether these PPAR␥ standing of normal physiology and disease, as well as our ability to intervene therapeutically. First, the multiple ligands or ligand precursors enter adipose cell precursors directly from the bloodstream or are first stored in levels of feedback control help to explain how most individuals maintain a rather impressive control of body a membrane lipid compartment. The mechanisms leading to ligand import or generation of PPAR␥ ligands weight. In order to maintain a weight change of less than 10 Kg over a 10 year period, an adult of 70 Kg Ultimately, our increased appreciation for the complex and cyclical nature of energy balance controls suggests must maintain greater than a 98% congruence between energy expenditure and energy intake. Surely this must caution if not modesty as our reductionist approaches, so useful in generating specific molecular targets, are depend on multiple levels of feedback control involving signals between the regulatory centers in the hypothalaapplied to the in vivo settings. It is possible that unexpected problems will develop as we test new drugs mus and adipose mass, food intake, and energy expenditure. Secondly, one might predict that experimental to control food intake, increase energy expenditure, or directly manipulate fat cell development. However, perturbations in various parts of this system would cause unexpected or even paradoxical results. Indeed, these very same interrelationships among complex physiological systems may allow for compensation and it was considered an intriguing mystery for years how monogenic mutations such as ob and db could cause allow new "set points" to be achieved without disastrous complications. An example of this could be the developboth increased food intake and decreased thermogenesis. This was only explained when the absence of leptin ment of antagonists to PPAR␥ as a treatment for obesity through the direct inhibition of fat cell formation. Even was shown to cause both of these effects. More recently, mice with a reduction in brown fat through expression if we assume that such molecules will be developed, and that they effectively decrease fat cell number without of a tissue-specific toxigene were found to develop obesity, with the expected decrease in thermogenesis (Lowadversely affecting insulin sensitivity, the continuation of energy intake at the same rate that induced obesity ell et al., 1993). Completely unexpected, however, was the increase in food intake that these mice exhibit. Since would require that this energy be stored as lipid in other tissues, such as liver or muscle, or remain in the blood leptin levels are very high rather than deficient in these mice , this argues strongly for as stream. These are all very problematic outcomes. Only if reduced fat cell number causes a compensatory deyet undiscovered regulatory pathways from brown fat to the brain. Along similar lines, beta 3-selective adrencrease in food intake or increase in energy expenditure could such an approach be useful. Fortunately, such a ergic agonists, developed as anti-obesity drugs that would stimulate these fat-selective receptors and inscenario is now conceivable. A reduction in adipose cell number would presumably lead to an increase in the crease ␤-oxidation of fatty acids and energy expenditure acutely reduce food intake and stimulate insulin secresize of those cells and hence, increased leptin synthesis. Furthermore, blockage of PPAR␥ itself might have a tion in mice (Susulic et al., 1995) through as yet unknown mechanisms that are independent of leptin (Mantzoros similar effect at the level of the leptin promoter. If increased leptin in this context caused reduced food inet al., 1996) .
The cyclical nature of energy homeostatic mechatake and increased energy expenditure, a beneficial cycle and development of a new, lower set-point might be nisms also suggest that significant disorders of energy balance could result from primary lesions at sites in achieved. Of course, this scenario is highly speculative but illustrates the complications and opportunities that these pathways that are not necessarily directly involved in controlling food intake. This could explain the exthis new knowledge now affords. tremely heterogeneous and complex nature of the genetics of human obesity. While studies of identical twins Acknowledgments reared apart versus together have argued that a large Journal limitations on the number of permissable citations have percentage of this disorder is genetically determined, prevented us from citing many additional important contributions mapping of obesity genes in humans indicates the made by workers in these fields. We regret that these references involvement of a large number of loci (Bouchard, 1995) .
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